
San Diego, CA — The National Cancer Institute (NCI) has awarded biomedical device start-up NanoSort, Inc. a 2 year, $297,000 Small Business Innovation Research (SBIR) grant and a 9-month, $198,000 contract. NanoSort will develop devices to detect circulating tumor cells (CTCs)—an emerging target in cancer diagnostics— using two novel approaches. NanoSort applies lab-on-a-chip technologies to drastically reduce the size and cost of flow cytometers while maintaining high…
ContinueAdded by Jose Morachis on September 27, 2011 at 10:00pm — No Comments
© 2013 Created by ScholarNexus, LLC.
